Avanos Medical (AVNS) Net Margin (2016 - 2024)
Historic Net Margin for Avanos Medical (AVNS) over the last 11 years, with Q3 2024 value amounting to 0.94%.
- Avanos Medical's Net Margin fell 39200.0% to 0.94% in Q3 2024 from the same period last year, while for Dec 2024 it was 1.08%, marking a year-over-year increase of 66300.0%. This contributed to the annual value of 7.71% for FY2023, which is 119500.0% down from last year.
- Latest data reveals that Avanos Medical reported Net Margin of 0.94% as of Q3 2024, which was down 39200.0% from 1.46% recorded in Q2 2024.
- In the past 5 years, Avanos Medical's Net Margin ranged from a high of 20.65% in Q2 2021 and a low of 71.79% during Q4 2021
- Over the past 5 years, Avanos Medical's median Net Margin value was 0.29% (recorded in 2023), while the average stood at 5.82%.
- Its Net Margin has fluctuated over the past 5 years, first plummeted by -453000bps in 2021, then surged by 757500bps in 2022.
- Avanos Medical's Net Margin (Quarter) stood at 26.49% in 2020, then crashed by -171bps to 71.79% in 2021, then skyrocketed by 106bps to 3.96% in 2022, then tumbled by -107bps to 0.29% in 2023, then plummeted by -225bps to 0.94% in 2024.
- Its last three reported values are 0.94% in Q3 2024, 1.46% for Q2 2024, and 0.84% during Q1 2024.